Upregulation of Brca1 might contribute to the tumor suppression mediated by the deletion of Mbd2. In contrast, Mbd2 possibly acts as an activator of Fat2 and Dnajc5, as Mbd2-KO causes a reduction in the expression of these genes. The gene discussed is BRCA1; the disease is neoplasm.